Autologous blood or PRP vs placebo at 3 months' follow‐up
- Autologous blood and platelet‐rich plasma injection therapy for lateral elbow pain 2021 · Cochrane Headline outcomes onlyno estimate extracted8 studies · 523 participantsModerate
It is very uncertain whether autologous blood or PRP changes treatment success (> 25% improvement in pain or function) compared with placebo at 3 months' follow‐up (very low certainty).
It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events  compared with placebo at 3 months' follow‐up (very low certainty).
Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).
Autologous platelet concentrate (PRP/PRF) in socket showed no clear difference in swelling (mean) compared with no blood product (conventional); GRADE not reported.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Autologous platelet concentrate (PRP/PRF) in socket may leads to lower alveolar osteitis compared with no blood product (conventional) (low certainty).
Autologous platelet concentrate (PRP/PRF) in socket showed no clear difference in postoperative pain (mean) compared with no blood product (conventional); GRADE not reported.